%PDF-1.4
%
64 0 obj
<>
endobj
61 0 obj
<>
endobj
137 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-08-06T15:25:45Z
2024-03-29T00:04:01-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T00:04:01-07:00
application/pdf
Heather
2003-526.sept
uuid:99c3fb81-1dd1-11b2-0a00-830927bd7700
uuid:99c3fb84-1dd1-11b2-0a00-900000000000
endstream
endobj
50 0 obj
<>
endobj
51 0 obj
<>
endobj
65 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 36 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 38 0 R/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 40 0 R/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 42 0 R/Type/Page>>
endobj
19 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 44 0 R/Type/Page>>
endobj
167 0 obj
[171 0 R]
endobj
168 0 obj
<>stream
q
0 0 612 783 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6283 0.7779 -0.7779 0.6283 8.2321 49.765 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 783 m
0 783 l
f
q
-1 784 587 -785 re
W n
q
0 783.03 612 -783 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 46 732.5293 Tm
[(37.)-875.1 (Slothuus U, Brooks RG. )17.7 (W)39.8 (illingness to pay in arthritis: a Danish)]TJ
2.175 -1.25 Td
(contribution. Rheumatology Oxford 2000;39:791-9.)Tj
-2.175 -1.25 Td
[(38.)-875.1 (O\325Brien B, )17.7 (V)59.8 (iramontes JL. )17.7 (W)39.9 (illingness to pay: )54.8 (A)-220.1 (valid and reliable)]TJ
2.175 -1.25 Td
(measure of health state preference? Med Decis Making)Tj
0 Tc 0 Tw 0 -1.25 TD
(1994;14:289-97.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(39.)-875.1 (W)79.9 (agner )17.7 (TH, Hu )17.7 (T)74 (, Duenas GV)128.8 (, Kaplan CP)110.7 (, Nguyen BH, Pasick RJ.)]TJ
2.175 -1.25 Td
[(Does willingness to pay vary by race/ethnicity? )54.8 (An analysis using)]TJ
T*
(mammography among low-income women. Health Policy)Tj
0 Tc 0 Tw T*
(2001;58:275-88.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(40.)-875.1 (Donaldson C, Shackley P)110.7 (,)-0.1 ( )54.8 (Abdalla M. Using willingness to pay to)]TJ
2.175 -1.25 Td
(value close substitutes: carrier screening for cystic fibrosis )Tj
T*
(revisited. Health Econ 1997;6:145-59.)Tj
-2.175 -1.25 Td
[(41.)-875.1 (Cross MJ, March LM, Lapsley HM, et al. Determinants of )]TJ
2.175 -1.25 Td
[(willingness to pay for hip and knee joint replacement sur)17.7 (gery for)]TJ
T*
(osteoarthritis. Rheumatology Oxford 2000;39:1242-8.)Tj
-2.175 -1.25 Td
[(42.)-875.1 (W)79.9 (agner )17.7 (TH, Hu )17.7 (T)74 (, Due\226as GV)128.8 (, Pasick RJ. )17.7 (W)39.9 (illingness to pay for)]TJ
2.175 -1.25 Td
(mammography: item development and testing among five ethnic)Tj
T*
(groups. Health Policy 2000;53:105-21.)Tj
-2.175 -1.25 Td
[(43.)-875.1 (Bullinger M, )54.8 (Alonso J, )54.8 (Apolone G, et al. )17.7 (T)35 (ranslating health status)]TJ
2.175 -1.25 Td
[(questionnaires and evaluating their quality: )17.7 (The IQOLA)-220.1 (Project)]TJ
T*
(Approach. J Clin Epidemiol 1998;51:913-23.)Tj
0.00729 Tw -2.175 -1.25 Td
[(44.)-875.1 (Frew )-17.7 (E, W)79.9 (olstenhome )-17.7 (JL, Whynes )-17.8 (DK. W)39.9 (illingness-to-pay )-17.7 (for)]TJ
0.02499 Tw 2.175 -1.25 Td
(colorectal cancer screening. Eur J Cancer 2001;37:1746-51.)Tj
-2.175 -1.25 Td
[(45.)-875.1 (Narbro K, Sjostrom L. )17.7 (W)39.8 (illingness to pay for obesity treatment. Int)]TJ
2.175 -1.25 Td
[(J )17.7 (T)69.9 (echnol )54.8 (Assess Health Care 2000;16:50-9.)]TJ
-2.175 -1.25 Td
[(46.)-875.1 (National Oceanic and )54.8 (Atmospheric )54.8 (Administration. Report of the)]TJ
2.175 -1.25 Td
[(NOAA)-220.2 (panel on contingent valuation. Federal Register)]TJ
0 Tc 0 Tw T*
(1993;58:4601-14.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(47.)-875.1 (Gafni )54.8 (A. )17.7 (W)39.8 (illingness to pay as a measure of benefits: Relevant)]TJ
2.175 -1.25 Td
(questions to ask in the context of public decision-making. Med)Tj
T*
(Care 1991;29:1246-52.)Tj
-2.175 -1.25 Td
[(48.)-875.1 (Morisson GC, Gyldmark M. )54.8 (Appraising the use of contingent )]TJ
2.175 -1.25 Td
(valuation. Health Econ 1992;1:233-43.)Tj
-2.175 -1.25 Td
[(49.)-875.1 (The EuroQol Group. Euro Qol \321 a new facility for the )]TJ
2.175 -1.25 Td
(measurement of health-related quality of life. Health Policy)Tj
0 Tc 0 Tw T*
(1990;16:199-208.)Tj
-0.00011 Tc 0.02499 Tw 30.825 43.75 Td
[(50.)-875.1 (Lorig KR, Cox )17.7 (T)74 (,)-0.1 ( Cuevas )36.8 (Y)128.9 (, Kraines GR. Conver)17.7 (ging and)]TJ
2.175 -1.25 Td
[(diver)17.7 (ging beliefs about arthritis: Caucasian patients, Spanish)]TJ
T*
[(speaking patients, and physicians. J Rheumatol 1984;1)36.8 (1:76-9.)]TJ
-2.175 -1.25 Td
[(51.)-875.1 (Ibrahim SA, Siminof)17.7 (f LA, Burant CJ, Kwoh K. Understanding)]TJ
2.175 -1.25 Td
[(ethnic dif)17.7 (ferences in the utilization of joint replacement for)]TJ
T*
[(osteoarthritis. )17.7 (The role of patient-level factors. Med Care 2002;40)]TJ
0 Tw T*
(Suppl:I44-51.)Tj
0.02499 Tw -2.175 -1.25 Td
[(52.)-875.1 (Cross MJ, March LM, Lapsley HM, et al. Determinants of )]TJ
2.175 -1.25 Td
[(willingness to pay for hip and knee joint replacement sur)17.7 (gery for)]TJ
T*
(osteoarthritis. Rheumatology Oxford 2000;39:1242-8.)Tj
-2.175 -1.25 Td
[(53.)-875.1 (Corbie-Smith G, )17.7 (Thomas SB, )17.7 (W)39.9 (illiams MV)128.8 (, Moody-A)91.7 (yers S.)]TJ
2.175 -1.25 Td
[(Attitudes and beliefs of )54.8 (African )54.8 (Americans toward participation in)]TJ
T*
(medical research. J Gen Intern Med 1999;14:537-46.)Tj
-2.175 -1.25 Td
[(54.)-875.1 (Freimuth )17.7 (V)128.9 (,)-0.1 ( Quinn S, )17.7 (Thomas S, Cole G, Zook E, Duncan )17.7 (T)74 (.)]TJ
2.175 -1.25 Td
[(African )54.8 (Americans\325)-201.1 (views on research and the )17.7 (T)35 (uskegee syphilis)]TJ
T*
[(study)64.9 (. Soc Sci Med 2001;52:797-808.)]TJ
-2.175 -1.25 Td
[(55.)-875.1 (O\325Malley K, Haidet P)110.7 (, Sharf B, et al. )17.7 (T)35 (rust in physician, facility)64.8 (,)]TJ
2.175 -1.25 Td
[(system: qualitative dif)17.7 (ferences between ethnic groups [abstract].)]TJ
T*
[(T)69.9 (wentieth )54.8 (Annual Meeting, )17.7 (V)128.9 (A)-220.1 (Health Services Research and)]TJ
T*
[(Development, February 2002; )17.7 (W)79.9 (ashington, DC.)]TJ
-2.175 -1.25 Td
[(56.)-875.1 (Olsen JA, Smith RD. )17.7 (Theory versus practice: )54.8 (A)-220.1 (review of )]TJ
2.175 -1.25 Td
[(\324willingness-to-pay\325)-201.1 (in health and health care. Health Econ)]TJ
0 Tc 0 Tw T*
(2001;10:39-52.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(57.)-875.1 (Kartman B, )54.8 (Andersson F)79.7 (,)-0.1 ( Johannesson M. )17.7 (W)39.8 (illingness to pay for)]TJ
2.175 -1.25 Td
(reductions in angina pectoris attacks. Med Decis Making)Tj
0 Tc 0 Tw T*
(1996;16:248-53.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(58.)-875.1 (Johannesson M, O\325Conor RM, Kobelt-Nguyen G, )54.8 (Attiasson )54.8 (A.)]TJ
2.175 -1.25 Td
[(W)39.9 (illingness to pay for incontinence symptoms. Br J Urol)]TJ
0 Tc 0 Tw T*
(1997;80:552-62.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(59.)-875.1 (Gyldmark M, Morrison GC. Demand for health care in Denmark:)]TJ
2.175 -1.25 Td
(results of a national sample survey using contingent valuation. Soc)Tj
T*
(Sci Med 2001;53:1023-36.)Tj
ET
0 0 0 1 K
43 72 m
547 72 l
S
BT
/T1_2 1 Tf
8 0 0 8 413.3613 53.9844 Tm
(The Journal of Rheumatology 2004; 31:9)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(1818)Tj
ET
0 0 0 0 k
/GS0 gs
96.25 76.75 396.47 -10.83 re
f*
0.5 w
96.25 76.75 396.47 -10.83 re
S
Q
Q
q
0 0 612 783 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
110.368 69 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 8 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
44 0 obj
<>stream
8;Z\7$a.B$#ikn#j>tbY?q`qRG&9*N_UJ/.1uVpud8MXp(8<#LrlQ27K!o=h\S^Tc
[af5!J,*;25O-Z/q,*4!A;m/_h_bCk;IMBJZ7@qRP`QYm=]Q9qk7`9K@O=`JA?:]o1b
PO&[,=Hg[kQp,B1LIPjoU@0rX6FX8K1LhWi1OY7MK?CJ>(M0<^S9qmjT1eTgZ8-#D
YptqC7+!&gh7D3J(dDnrg`4BK'-3jsU\:[E&oe^NL./L33R5C>Za_gOh?[_2G-N[IJ=QXjfq's7`bGRQdUEI7*,9VA#.iaAJU]M=T#r
endstream
endobj
48 0 obj
[/Indexed/DeviceRGB 255 47 0 R]
endobj
47 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
120 0 obj
<>
endobj
72 0 obj
<>
endobj
67 0 obj
<>
endobj
103 0 obj
<>
endobj
142 0 obj
<>
endobj
68 0 obj
<>
endobj
95 0 obj
<>stream
HU{PSg
H[ڎVխT@B4!G!